Nanomedicine-Empowered CAR-T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy
International Journal of Nanomedicine · 2026
DOI: 10.2147/ijn.s628321 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Can Huang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The People's Hospital of Baoan, Shenzhen, Guangdong, 518101, People's Republic of China. Hauptthemen laut MEDLINE: Multiple Myeloma, Nanomedicine, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The People's Hospital of Baoan, Shenzhen, Guangdong, 518101, People's Republic of China.
- Department of Hematology, The Second Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, 518101, People's Republic of China.
- Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, 310003, People's Republic of China.
- School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, 610550, People's Republic of China.
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, People's Republic of China.
- Institute of Biomedical Sciences, Fudan University, Shanghai, 200032, People's Republic of China.
ORCID-Profile: Can Huang, Yuanyin Teng, Xiang Deng, Gaochun Zeng
Zitieren
APA
Huang, C., Zhang, X., Teng, Y., Zhang, Z., Wang, B., Gu, P., Deng, X., Wang, D., Xiao, H., Zou, L., Zhao, M., Zheng, C., Zeng, G., Li, J., & Huang, Z. (2026). Nanomedicine-Empowered CAR-T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s628321
Vancouver
Huang C, Zhang X, Teng Y, Zhang Z, Wang B, Gu P, et al. Nanomedicine-Empowered CAR-T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s628321
BibTeX
@article{Huang2026,
author = {Huang, Can and Zhang, Xuyan and Teng, Yuanyin and Zhang, Zhongsong and Wang, Bing and Gu, Panpan and Deng, Xiang and Wang, Dianwen and Xiao, Hongli and Zou, Lingli and Zhao, Meng and Zheng, Caifeng and Zeng, Gaochun and Li, Jianyun and Huang, Zoufang},
title = {Nanomedicine-Empowered CAR-T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy},
journal = {International Journal of Nanomedicine},
year = {2026},
doi = {10.2147/ijn.s628321}
}
EUVIMED